Want to know more about medical research on Ayahuasca? Tune into our conversation with Dr, Simon Ruffell and WaiFung Tsang of the Psychae Institute at University of Melbourne & Kings College London, respectively. Simon and WaiFung talk us through their journey to psychedelics – from self-funding an observational study around ayahuasca, through to receiving funding from the UK government to further their fantastic research!

Professionally Cannabis

Dr. Simon Ruffell & WaiFung Tsang; Psychae Institute at the University of Melbourne & Kings College London

Earlier this year, we caught up with Josh Kirby, the Co-Founder & CEO of Kin Slips – a California-based brand looking to redefine cannabis delivery mechanisms through their sublingual strips. Josh takes us on his journey from making brownies at university to designing innovative products for the California cannabis market, including some M&A along the way. Check out Josh’s interview today!

Josh Kirby, Co-Founder & CEO of Kin Slips

Tune into this week’s pod with one of the OGs of cannabis research - Professor Roger Pertwee, Emeritus Professor at the University of Aberdeen. In no uncertain terms, across over 50 years of cannabis research, Roger is behind many of the scientific breakthroughs that underpin our understanding of the pharmacology of cannabis and the endocannabinoid system. Having collaborated with Dr. Raphael Mechoulam in the early days of cannabis research, Roger is a true legend with an amazing story.

Professor Roger Pertwee, Emeritus Professor at the University of Aberdeen

Earlier this year, we spoke with another psychedelics and cannabis pioneer, Ronan Levy, Co-Founder & Executive Chairman of Field Trip Health. Within a candid conversation, Ronan discusses how Field Trip have exponentially scaled their business, the differences and similarities between how the psychedelics and cannabis industries will continue to grow, developing novel psychedelic compounds, and the journey from developing new drugs to commercialisation. Tune into Ronan’s interview today!

Ronan Levy, Co-Founder & Executive Chairman, Field Trip

Earlier this year, we spoke with Peter Crock, the CEO of Australian cannabis operator, Cann Group Ltd. As the first company in Australia granted a cultivation and research license for medical cannabis, Peter talks through the current state of play in the domestic market, Cann Group’s acquisitions and expansion into Europe, R&D initiatives and how to keep shareholders happy! Tune into Peter’s episode today to find out more.

Peter Crock, CEO of Cann Group

For this episode, we speak with cannabis and psychedelics investors, Bek Muslimov and Nikolay Tretiyakov of Leafy Tunnel. Over the interview, we hear about the similarities and differences between cannabis and psychedelics investing, what investors should look for in companies and their founders, and the sectors that have the greatest growth potential. Tune into their episode today!

Bek Muslimov & Nikolay Tretiyakov, Co-Founders of Leafy Tunnel

Earlier this year, we caught up with returning guest to the pod and a psychedelics and cannabis pioneer, Bruce Linton.   Over the interview, Bruce takes us through his journey into psychedelics and gives his insight into public policy, the future of mental health treatment and how investors should approach this burgeoning market. Tune in today!

Bruce Linton, Serial Entrepreneur & Founder

This week's episode welcomes Karim Webb, Entrepreneurial Activist and CEO of 4thMVMT. Social equity initiatives are increasingly being worked into cannabis legalisation legislation in some U.S. states, but do they go far enough? Tune into Karim's interview to find out more!

Karim Webb, Entrepreneurial Activist & CEO of 4thMVMT

Check out this week’s episode with Tracy Ryan, the Founder of NKore, CannaKids and Saving Sophie. Perhaps best known for her role in the award-winning film, Weed the People, in which Tracy’s baby daughter, Sophie, is treated with medical cannabis, Tracy has gone on to lead 3 organisations; most recently NKore, a research firm focussed on natural killer cell therapeutics and cannabis for cancer care.

Tracy Ryan, Founder of NKore, CannaKids and Saving Sophie

Tune into Part 2 of our bumper first episode of the Professionally Psychedelics Podcast with Dr. David Feifel.   As Professor Emeritus at UC San Diego & Founder of Kadima Neuropsychiatry Institute, David is one of the pioneers of psychedelic medicine research and ketamine therapy; a true leader at the forefront of the biggest development in mental health for 50 years.

Part 2 | Dr. David Feifel, Professor Emeritus at UC San Diego & Founder of Kadima Neuropsychiatry Institute

Earlier this year, we discussed everything French Cannabis with Benjamin-Alexandre Jeanroy, the Co-Founder & CEO of Augur Associates.   The long-awaited two year ‘cannabis experiment’ in France was given the green light in March, providing access to medical cannabis and cannabis medicines for approximately 3000 patients. Benjamin talks through how this will work in practice, the way in which patients will be able to access medicine, the companies that are supplying the product, and the socio-political status of cannabis in France – one of the largest consumers of the plant in Europe.

Benjamin-Alexandre Jeanroy, Co-Founder & CEO at Augur Associates

For our long-awaited first episode of Professionally Psychedelics, we had the honour of speaking with a pioneer of psychedelic medicine, Dr. David Feifel. Tune into part 1 of David’s episode today!   As Professor Emeritus at UC San Diego & Founder of Kadima Neuropsychiatry Institute, David is one of the pioneers of psychedelic medicine research and ketamine therapy; a true leader at the forefront of the biggest development in mental health for 50 years.

Part 1 | Dr. David Feifel, Professor Emeritus at UC San Diego & Founder of Kadima Neuropsychiatry Institute

After a short summer break, for this week’s episode, we had the pleasure of speaking with Cameron Clarke, the CEO of Sunderstorm.   As a long-standing advocate for plant medicines and the leader of California-based cannabis CPG brand, Sunderstorm, Cameron takes us on his journey from commercialising the Acai Berry in the US, through to creating high-potency, fast onset, nano-formulated cannabis products for the North American adult use market.

Cameron Clarke, CEO at Sunderstorm

For this week’s episode, we had the pleasure of speaking with Dr Michele Ross, the Founder of AURA Therapeutics. As a clinician, patient, author and entrepreneur with deep, first-hand experience in using a plethora of plant medicines therapeutically, Michele talks through how she’s able to mediate the symptoms of her fibromyalgia, how she integrates both cannabis and Kratom into her daily routine, the science behind it, and why over 10m people in the U.S. are using Kratom! www.professionallycannabispodcast.com

Dr. Michele Ross, Founder of AURA Therapeutics

For this week’s episode, we had the pleasure of speaking with Kyle Detwiler, the CEO of international cannabis operator, Clever Leaves.   In a wide-ranging conversation, Kyle gives great insight into how Clever Leaves have developed as a business since our last conversation with the company (50 episodes ago!), discussing distributing GMP-grade cannabis products into emerging medical markets, partnering with international pharma partners and having political influence in Colombia and beyond!

Kyle Detwiler, CEO at Clever Leaves

Professionally Cannabis Is the show for Investors, Entrepreneurs and Connoisseurs of the burgeoning cannabis industry. Each week your intrepid and handsome hosts Oscar Hausman and Jonny Wiser will bring you exclusive interviews with industry leaders to bring their personal perspective on this high growth multi-billion dollar economy driving, medically life-changing plant.

hubhopper

Professionally Cannabis

hubhopper